Investor Relations Contact Us Careers
Nasdaq: FEMY
Media

Femasys in the
conversation.

Podcasts, press coverage, educational videos, webinars, blog posts, and press resources — everything you need to stay current on Femasys and women’s health innovation.

Couple reading Femasys content on a tablet
Featured

— Recent News

All Recent News →
News GLOBE NEWSWIRE
Femasys Expands Fertility Care Portfolio in Europe with CE Mark Approval for FemHSG(TM) Catheter
May 13, 2026 Read →
News GLOBE NEWSWIRE
Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update
May 8, 2026 Read →
News GLOBE NEWSWIRE
Femasys Enables OB/GYNs to Deliver First-Line Fertility Treatment with Initial Commercial Use of FemaSeed Complete
May 5, 2026 Read →

— Videos

All Videos →
Video Physician Perspective
Dr. Bedient on FemaSeed
May 1, 2026 Watch →
Video Webinar Recap
An Introduction to FemaSeed & Outcomes of Clinical Trial
Apr 20, 2026 Watch →
Video Patient Story
One Patient’s Journey: From Diagnosis to Pregnancy with FemaSeed
Apr 10, 2026 Watch →

— Podcasts

All Podcasts →
Health Innovation Matters The Future of Fertility and Non-Surgical Birth Control with Kathy Lee-Sepsick
Apr 5, 2026 Listen →
Fertility Docs Uncensored Intratubal insemination: Another Option in Fertility Treatment
May 20, 2025 Listen →

— Webinars

All Webinars →
ON DEMAND
Innovations in Infertility, Featuring Dr. Bedient
May 15, 2026 Watch →
ON DEMAND
FemaSeed Webinar: An Introduction to FemaSeed & Clinical Trial Outcomes
Dec 5, 2024 Watch →

— From the Blog

All From the Blog →
What Is Male-Factor Infertility? A Plain-Language Guide for Couples
May 20, 2026 Read →
Femasys Expands Fertility Care Portfolio in Europe with CE Mark Approval for FemHSG™ Catheter
May 13, 2026 Read →
Press Resources

Everything
journalists need.

Download official logos, executive headshots, product photography, and company fact sheets. For interview requests or additional materials, contact our media relations team directly.

Logo Package
SVG, PNG — light, dark, and color variants
Company Overview
One-page fact sheet • Updated Q2 2026
Product Animations
Animations for FemaSeed, FemBloc, and FemCerv
Media Relations
1-877-336-2562
Investor Relations
ir.femasys.com

For urgent media inquiries or to arrange an executive interview, please include your outlet name, story angle, and publication deadline in your email.

Stay Current

Women’s health news, delivered.

Get the latest Femasys updates — from fertility portfolio commercial progress and FemBloc® U.S. trial milestones to educational events and press releases — directly in your inbox.

You can unsubscribe from these communications at any time.
For more information on our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.